Patents by Inventor Fredrik WAGBERG

Fredrik WAGBERG has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Benzoxazinone derivatives for treatment of skin diseases
    Patent number: 10072024
    Abstract: The present invention relates to methods and compositions for inhibiting the activity of skin proteases, especially human kallikrein 7 (KLK7), human kallikrein 5 (KLK5), and human kallikrein 14 (KLK14). More specifically, the invention relates to the use of substituted 3,1-benzoxazin-4-ones being selective inhibitors of human skin kallikreins for the treatment of skin diseases, more specifically for the treatment of inflammatory skins diseases, especially Netherton syndrome.
    Type: Grant
    Filed: June 5, 2017
    Date of Patent: September 11, 2018
    Assignee: SIXERA PHARMA AB
    Inventors: Fredrik Wagberg, Goran Leonardsson
  • BENZOXAZINONE DERIVATIVES FOR TREATMENT OF SKIN DISEASES
    Publication number: 20170267692
    Abstract: The present invention relates to methods and compositions for inhibiting the activity of skin proteases, especially human kallikrein 7 (KLK7), human kallikrein 5 (KLK5), and human kallikrein 14 (KLK14). More specifically, the invention relates to the use of substituted 3,1-benzoxazin-4-ones being selective inhibitors of human skin kallikreins for the treatment of skin diseases, more specifically for the treatment of inflammatory skins diseases, especially Netherton syndrome.
    Type: Application
    Filed: June 5, 2017
    Publication date: September 21, 2017
    Inventors: Fredrik WAGBERG, Goran LEONARDSSON
  • Benzoxazinone derivatives for treatment of skin diseases
    Patent number: 9695194
    Abstract: The present invention relates to methods and compositions for inhibiting the activity of skin proteases, especially human kallikrein 7 (KLK7), human kallikrein 5 (KLK5), and human kallikrein 14 (KLK14). More specifically, the invention relates to the use of substituted 3,1-benzoxazin-4-ones being selective inhibitors of human skin kallikreins for the treatment of skin diseases, more specifically for the treatment of inflammatory skins diseases, especially Netherton syndrome.
    Type: Grant
    Filed: January 22, 2015
    Date of Patent: July 4, 2017
    Assignee: SIXERA PHARMA AB
    Inventors: Fredrik Wagberg, Goran Leonardsson
  • BENZOXAZINONE DERIVATIVES FOR TREATMENT OF SKIN DISEASES
    Publication number: 20170002021
    Abstract: The present invention relates to methods and compositions for inhibiting the activity of skin proteases, especially human kallikrein 7 (KLK7), human kallikrein 5 (KLK5), and human kallikrein 14 (KLK14). More specifically, the invention relates to the use of substituted 3,1-benzoxazin-4-ones being selective inhibitors of human skin kallikreins for the treatment of skin diseases, more specifically for the treatment of inflammatory skins diseases, especially Netherton syndrome.
    Type: Application
    Filed: January 22, 2015
    Publication date: January 5, 2017
    Inventors: Fredrik WAGBERG, Goran LEONARDSSON